Showing results (1-10 of 402) with videos related to
Sort By:
Pageof 41
Expert Review of Neurotherapeutics|June 10, 2017
Beyond serotonin: newer antidepressants in the futureGopalkumar Rakesh, Chi-Un Pae, Prakash S MasandExpert Opinion on Drug Safety|April 27, 2022
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerabilityMichael D Kritzer, Chi-Un Pae, Prakash S MasandPsychiatry Investigation|May 26, 2017
Development of a Diverse Learning Experience for Diverse Psychiatry Resident Needs: A Four-Year Biological Psychiatry Curriculum Incorporating Principles of Neurobiology, Psychopharmacology, and Evidence-Based PracticeAndrew J Muzyk, Jane P Gagliardi, Gopalkumar Rakesh, et al.Clinical Drug Investigation|October 3, 2012
Achieving and sustaining remission in bipolar I disorder with ziprasidone : a post hoc analysis of a 24-week, double-blind, placebo-controlled studyChi-Un Pae, Prakash S Masand, Francine S Mandel, et al.Psychiatry Investigation|January 5, 2010
Does pregabalin have neuropsychotropic effects?: a short perspectiveDavid M Marks, Ashwin A Patkar, Prakash S Masand, et al.International Clinical Psychopharmacology|December 9, 2008
Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot studyChi-Un Pae, David M Marks, Changsu Han, et al.Expert Opinion on Investigational Drugs|March 20, 2013
Atypical antipsychotics as a possible treatment option for irritable bowel syndromeChi-Un Pae, Soo-Jung Lee, Changsu Han, et al.CNS Drugs|December 5, 2009
Atypical depression: a comprehensive reviewChi-Un Pae, Haresh Tharwani, David M Marks, et al.Postgraduate Medicine|January 29, 2010
Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptomsHo-Jun Seo, Manmohandeep Singh Sohi, Ashwin A Patkar, et al.Expert Opinion on Pharmacotherapy|June 12, 2009
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressantsChi-Un Pae, David M Marks, Ashwin A Patkar, et al.Pageof 41